James Christensen's Insider Trades & SAST Disclosures
James Christensen's most recent trade in Boundless Bio Inc. was a trade of 13,219 Stock Option done . Disclosure was reported to the exchange on March 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Christensen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boundless Bio Inc. | James Christensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Mirati Therapeutics Inc | Christensen James | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 18 Dec 2023 | 2,387 | 141,645 (0%) | 0% | 57.5 | 137,253 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 146,420 (0%) | 0% | 37 | 824,989 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 24 May 2023 | 619 | 124,123 (0%) | 0% | 45.3 | 28,035 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 45,456 | 45,456 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,864 | 124,742 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 1,358 | 98,765 (0%) | 0% | 42.4 | 57,549 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 887 | 97,878 (0%) | 0% | 42.4 | 37,593 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.60 per share. | 04 Jan 2023 | 1,949 | 100,123 (0%) | 0% | 46.6 | 90,823 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 43.00 per share. | 16 Dec 2022 | 2,410 | 102,072 (0%) | 0% | 43.0 | 103,624 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.19 per share. | 02 Dec 2022 | 1,726 | 104,482 (0%) | 0% | 90.2 | 155,667 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 19,149 | 106,089 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 63.54 per share. | 23 May 2022 | 624 | 86,804 (0%) | 0% | 63.5 | 39,649 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 17,821 | 17,821 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 10,755 | 88,055 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 120.51 per share. | 14 Jan 2022 | 627 | 87,428 (0%) | 0% | 120.5 | 75,558 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 147.72 per share. | 04 Jan 2022 | 1,442 | 77,300 (0%) | 0% | 147.7 | 213,017 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 154.34 per share. | 24 May 2021 | 435 | 53,850 (0%) | 0% | 154.3 | 67,138 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 10,979 | 10,979 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 7,023 | 54,285 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 210.28 per share. | 06 Jan 2021 | 1,430 | 47,262 (0%) | 0% | 210.3 | 300,700 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 215.86 per share. | 06 Jan 2021 | 29 | 48,692 (0%) | 0% | 215.9 | 6,260 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 5,000 | 8,747 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 02 Nov 2020 | 5,000 | 44,437 (0%) | 0% | 5.5 | 27,500 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 4,284 | 21,757 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 02 Nov 2020 | 4,284 | 48,721 (0%) | 0% | 5.4 | 23,134 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 02 Nov 2020 | 1,595 | 39,437 (0%) | 0% | 25.0 | 39,859 | Common Stock |
| Mirati Therapeutics Inc | James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 1,595 | 40,825 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges